Maples Group Wins 12 China Deals of the Year Awards 2022

请点击此处阅读简体版本
請點擊此處閱讀繁體版本

Maples and Calder, the Maples Group's law firm, is pleased to announce that its Asia practices have received 12 awards at the China Deals of the Year 2022.  Published annually by the China Business Law Journal, the report recognises the year's most significant China-related deals, taking into account overall significance, complexity, deal size and innovative nature of the deals and cases. 

Multi-disciplinary teams of lawyers across the firm's Asia Corporate, Finance, Funds & Investment Management and Dispute Resolution & Insolvency practices advised on the following award-winning transactions in the Equity Capital Market, Debt Restructuring, Loans & Financings and Merger & Acquisitions categories:

Equity Capital Markets: 

• Aquila Acquisition's SPAC debuts on the HKEX 
• Asia Innovations Group's SPAC listing on NYSE
• ECARX's SPAC listing on Nasdaq 
• Li Auto's USD2bn follow-on offering
• Tim Hortons China lists on Nasdaq via SPAC
• NIO's listing by way of introduction in Hong Kong and Singapore 

Debt Restructuring:

• Modern Land restructuring of USD1.3bn offshore notes 

Loans & Financings:

• Royalty-backed financing of Yisheng Biopharma 

Mergers & Acquisitions:

• EQT's USD7.5bn merger with BPEA 
• JD Property completes mandatory acquisition of Chinese logistics assets
• NaaS merges with RISE Education to list on Nasdaq
• United Family Hospital privatisation 

Commenting on the award-wins, Partner and Head of the firm's Asia Corporate practice, Matt Roberts said, "We are delighted to have assisted our Asia based clients on a number of significant and innovative standout and complex transactions in 2022, demonstrating our team's deep expertise and track record in executing the very best mandates in the region, in particular those from China. We are committed to support our clients in achieving more successes in 2023 and beyond." 

Find out more about the 'China Deals of the Year 2022'